Literature DB >> 26921506

Inhibition of p300 histone acetyltransferase activity in palate mesenchyme cells attenuates Wnt signaling via aberrant E-cadherin expression.

Dennis R Warner1, Scott C Smith1, Irina A Smolenkova1, M Michele Pisano2, Robert M Greene1.   

Abstract

p300 is a multifunctional transcriptional coactivator that interacts with numerous transcription factors and exhibits protein/histone acetyltransferase activity. Loss of p300 function in humans and in mice leads to craniofacial defects. In this study, we demonstrated that inhibition of p300 histone acetyltransferase activity with the compound, C646, altered the expression of several genes, including Cdh1 (E-cadherin) in mouse maxillary mesenchyme cells, which are the cells that give rise to the secondary palate. The increased expression of plasma membrane-bound E-cadherin was associated with reduced cytosolic β-catenin, that led to attenuated signaling through the canonical Wnt pathway. Furthermore, C646 reduced both cell proliferation and the migratory ability of these cells. These results suggest that p300 histone acetyltransferase activity is critical for Wnt-dependent palate mesenchymal cell proliferation and migration, both processes that play a significant role in morphogenesis of the palate.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C646; Craniofacial; Embryo; Histone acetyltransferase; Palate; Wnt; p300

Mesh:

Substances:

Year:  2016        PMID: 26921506      PMCID: PMC4818121          DOI: 10.1016/j.yexcr.2016.02.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.

Authors:  Nicholas T Crump; Catherine A Hazzalin; Erin M Bowers; Rhoda M Alani; Philip A Cole; Louis C Mahadevan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Functional analysis of CBP/p300 in embryonic orofacial mesenchymal cells.

Authors:  D R Warner; M M Pisano; R M Greene
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

4.  Transforming growth factor-beta modulation of glycosaminoglycan production by mesenchymal cells of the developing murine secondary palate.

Authors:  M D'Angelo; R M Greene
Journal:  Dev Biol       Date:  1991-06       Impact factor: 3.582

5.  Negative interplay of retinoic acid and TGF-β signaling mediated by TG-interacting factor to modulate mouse embryonic palate mesenchymal-cell proliferation.

Authors:  Xiaozhuan Liu; Huanhuan Zhang; Liyun Gao; Yanyan Yin; Xinjuan Pan; Zhitao Li; Ning Li; Haozhe Li; Zengli Yu
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2014-12-04

6.  Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects.

Authors:  Yoshihiro Ito; Jae Yong Yeo; Anna Chytil; Jun Han; Pablo Bringas; Akira Nakajima; Charles F Shuler; Harold L Moses; Yang Chai
Journal:  Development       Date:  2003-11       Impact factor: 6.868

7.  Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.

Authors:  Jose Viosca; Jose P Lopez-Atalaya; Roman Olivares; Richard Eckner; Angel Barco
Journal:  Neurobiol Dis       Date:  2009-10-12       Impact factor: 5.996

8.  Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development.

Authors:  Fenglei He; Wei Xiong; Xueyan Yu; Ramon Espinoza-Lewis; Chao Liu; Shuping Gu; Michiru Nishita; Kentaro Suzuki; Gen Yamada; Yasuhiro Minami; Yiping Chen
Journal:  Development       Date:  2008-10-23       Impact factor: 6.868

9.  A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells.

Authors:  Xiao-ning Gao; Ji Lin; Qiao-yang Ning; Li Gao; Yu-shi Yao; Ji-hao Zhou; Yong-hui Li; Li-li Wang; Li Yu
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

10.  Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.

Authors:  Gai Yan; Mark S Eller; Courtney Elm; Cecilia A Larocca; Byungwoo Ryu; Izabela P Panova; Beverley M Dancy; Erin M Bowers; David Meyers; Lisa Lareau; Philip A Cole; Sean D Taverna; Rhoda M Alani
Journal:  J Invest Dermatol       Date:  2013-04-18       Impact factor: 8.551

View more
  5 in total

1.  Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia.

Authors:  Ruei-Nian Li; Chien-Yu Li; Chien-Hung Lee; Chiung-Yu Peng; Ming-Tsang Wu
Journal:  Oncol Lett       Date:  2017-04-03       Impact factor: 2.967

Review 2.  Wnt signaling in orofacial clefts: crosstalk, pathogenesis and models.

Authors:  Kurt Reynolds; Priyanka Kumari; Lessly Sepulveda Rincon; Ran Gu; Yu Ji; Santosh Kumar; Chengji J Zhou
Journal:  Dis Model Mech       Date:  2019-02-04       Impact factor: 5.758

3.  Identification of histone malonylation in the human fetal brain and implications for diabetes-induced neural tube defects.

Authors:  Qin Zhang; Tanxi Cai; Zonghui Xiao; Dan Li; Chunlei Wan; Xiaodai Cui; Baoling Bai
Journal:  Mol Genet Genomic Med       Date:  2020-07-15       Impact factor: 2.183

4.  PBX-WNT-P63-IRF6 pathway in nonsyndromic cleft lip and palate.

Authors:  Lorena Maili; Ariadne Letra; Renato Silva; Edward P Buchanan; John B Mulliken; Matthew R Greives; John F Teichgraeber; Steven J Blackwell; Rohit Ummer; Ryan Weber; Brett Chiquet; Susan H Blanton; Jacqueline T Hecht
Journal:  Birth Defects Res       Date:  2019-12-11       Impact factor: 2.344

5.  MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity.

Authors:  Hongye Zhang; Ling Wang; Juan Bai; Wenyu Jiao; Mingxia Wang
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.